Prebiotic inulin as a treatment of obesity related nonalcoholic fatty liver disease through gut microbiota: a critical review

References

• Bäckhed, F., H. Ding, T. Wang, L. V. Hooper, G. Y. Koh, A. Nagy, C. F. Semenkovich, and J. I. Gordon. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 101 (44):15718–23. doi: 10.1073/pnas.0407076101.
   PubMed Web of Science ®Google Scholar
• Baxter, N. T., A. W. Schmidt, A. Venkataraman, K. S. Kim, C. Waldron, T. M. Schmidt, and M. J. Blaser. 2019. Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers. Mbio 10 (1):e02566-18. doi: .：e10.1128/mBio.02566-18.
   Web of Science ®Google Scholar
• Bianchi, F., A. L. Rocha Faria Duque, S. M. Isay Saad, and K. Sivieri. 2019. Gut microbiome approaches to treat obesity in humans. Applied Microbiology and Biotechnology 103 (3):1081–1094. doi: 10.1007/s00253-018-9570-8.
   PubMed Web of Science ®Google Scholar
• Boger, M. C. L., A. L. van Bueren, and L. Dijkhuizen. 2018. Cross-feeding among probiotic bacterial strains on prebiotic inulin involves the extracellular exo-inulinase of Lactobacillus paracasei strain W20. Applied and Environmental Microbiology 84 (21):e01539-18. doi: 10.1128/AEM.01539-18.
   PubMed Web of Science ®Google Scholar
• Bolam, D. N., and J. L. Sonnenburg. 2011. Mechanistic insight into polysaccharide use within the intestinal microbiota. Gut Microbes 2 (2):86–90. doi: 10.4161/gmic.2.2.15232.
   PubMed Web of Science ®Google Scholar
• Bouhnik, Y., L. Raskine, G. Simoneau, E. Vicaut, C. Neut, B. Flourie, F. Brouns, and F. R. Bornet. 2004. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: A double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. The American Journal of Clinical Nutrition 80 (6):1658–64. doi: 10.1134/S0036024409120073.
   PubMed Web of Science ®Google Scholar
• Brooks, L., A. Viardot, A. Tsakmaki, E. Stolarczyk, J. K. Howard, P. D. Cani, A. Everard, M. L. Sleeth, A. Psichas, J. Anastasovskaj, et al. 2017. Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety. Molecular Metabolism 6 (1):48–60. doi: 10.1016/j.molmet.2016.10.011.
   PubMed Web of Science ®Google Scholar
• Brunt, E. M., V. W.-S. Wong, V. Nobili, C. P. Day, S. Sookoian, J. J. Maher, E. Bugianesi, C. B. Sirlin, B. A. Neuschwander-Tetri, and M. E. Rinella. 2015. Nonalcoholic fatty liver disease. Nature Reviews Disease Primers 1 (1):1–22. doi: 10.1038/nrdp.2015.80.
   Google Scholar
• Buclaw, M. 2016. The use of inulin in poultry feeding: A review. Journal of Animal Physiology and Animal Nutrition 100 (6):1015–22. doi: 10.1111/jpn.12484.
   PubMed Web of Science ®Google Scholar
• Canfora, E. E., J. W. Jocken, and E. E. Blaak. 2015. Short-chain fatty acids in control of body weight and insulin sensitivity. Nature Reviews. Endocrinology 11 (10):577–91. doi: 10.1038/nrendo.2015.128.
   PubMed Web of Science ®Google Scholar
• Canfora, E. E., R. C. Meex, K. Venema, and E. E. Blaak. 2019. Gut microbial metabolites in obesity, NAFLD and T2DM. Nature Reviews. Endocrinology 15 (5):261–73. doi: 10.1038/s41574-019-0156-z.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., M. Osto, L. Geurts, and A. Everard. 2012. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3 (4):279–88. doi: 10.4161/gmic.19625.
   PubMed Web of Science ®Google Scholar
• Cantu-Jungles, T., and B. Hamaker. 2020. New view on dietary fiber selection for predictable shifts in gut microbiota. Mbio 11 (1):e02179-19. doi: 10.1128/mBio.02179-19.
   Web of Science ®Google Scholar
• Carpino, G., M. Del Ben, D. Pastori, R. Carnevale, F. Baratta, D. Overi, H. Francis, V. Cardinale, P. Onori, S. Safarikia, et al. 2020. Increased liver localization of lipopolysaccharides in human and experimental non-alcoholic fatty liver disease. Hepatology 72 (2):470–85. doi: 10.1002/hep.31056.
   PubMed Web of Science ®Google Scholar
• Chambers, E. S., C. S. Byrne, A. Rugyendo, D. J. Morrison, T. Preston, C. Tedford, J. D. Bell, L. Thomas, A. N. Akbar, N. E. Riddell, et al. 2019. The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease. Diabetes, Obesity & Metabolism 21 (2):372–6. doi: 10.1111/dom.13500.
   PubMed Web of Science ®Google Scholar
• Chambers, E. S., A. Viardot, A. Psichas, D. J. Morrison, K. G. Murphy, S. E. K. Zac-Varghese, K. MacDougall, T. Preston, C. Tedford, G. S. Finlayson, et al. 2015. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64 (11):1744–54. doi: 10.1136/gutjnl-2014-307913.
   PubMed Web of Science ®Google Scholar
• Chávez-Talavera, O., A. Tailleux, P. Lefebvre, and B. Staels. 2017. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology 152 (7):1679–94. e1673. doi: 10.1053/j.gastro.2017.01.055.
   PubMed Web of Science ®Google Scholar
• Chen, K., H. Chen, M. M. Faas, B. J. de Haan, J. Li, P. Xiao, H. Zhang, J. Diana, P. de Vos, and J. Sun. 2017. Specific inulin-type fructan fibers protect against autoimmune diabetes by modulating gut immunity, barrier function, and microbiota homeostasis. Molecular Nutrition & Food Research 61 (8):1601006. doi: 10.1002/mnfr.201601006.
   Web of Science ®Google Scholar
• Chijiiwa, R., M. Hosokawa, M. Kogawa, Y. Nishikawa, K. Ide, C. Sakanashi, K. Takahashi, and H. Takeyama. 2020. Single-cell genomics of uncultured bacteria reveals dietary fiber responders in the mouse gut microbiota. Microbiome 8 (1):5. doi: 10.1186/s40168-019-0779-2.
   PubMed Web of Science ®Google Scholar
• Chopyk, D. M., and A. Grakoui. 2020. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders. Gastroenterology 159 (3):849–63. doi: 10.1053/j.gastro.2020.04.077.
   PubMed Web of Science ®Google Scholar
• Chung, W. S. F., A. W. Walker, P. Louis, J. Parkhill, J. Vermeiren, D. Bosscher, S. H. Duncan, and H. J. Flint. 2016. Modulation of the human gut microbiota by dietary fibres occurs at the species level. BMC Biology 14 (1):3. doi: 10.1186/s12915-015-0224-3.
   PubMedGoogle Scholar
• Cockburn, D. W., and N. M. Koropatkin. 2016. Polysaccharide degradation by the intestinal microbiota and its influence on human health and disease. Journal of Molecular Biology 428 (16):3230–52. doi: 10.1016/j.jmb.2016.06.021.
   PubMed Web of Science ®Google Scholar
• De Preter, V., H. M. Hamer, K. Windey, and K. Verbeke. 2011. The impact of pre- and/or probiotics on human colonic metabolism: Does it affect human health? Molecular Nutrition & Food Research 55 (1):46–57. doi: 10.1002/mnfr.201000451.
   PubMed Web of Science ®Google Scholar
• De Vuyst, L., and F. Leroy. 2011. Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. International Journal of Food Microbiology 149 (1):73–80. doi: 10.1016/j.ijfoodmicro.2011.03.003.
   PubMed Web of Science ®Google Scholar
• Dehghan, P., B. P. Gargari, M. A. Jafar-Abadi, and A. Aliasgharzadeh. 2014. Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus: A randomized-controlled clinical trial. International Journal of Food Sciences and Nutrition 65 (1):117–23. doi: 10.3109/09637486.2013.836738.
   PubMed Web of Science ®Google Scholar
• Delzenne, N. M., C. Daubioul, A. Neyrinck, M. Lasa, and H. S. Taper. 2002. Inulin and oligofructose modulate lipid metabolism in animals: Review of biochemical events and future prospects. The British Journal of Nutrition 87 (Suppl 2):S255–S259. doi: 10.1079/BJNBJN/2002545.
   PubMed Web of Science ®Google Scholar
• den Besten, G., K. Lange, R. Havinga, T. H. van Dijk, A. Gerding, K. van Eunen, M. Müller, A. K. Groen, G. J. Hooiveld, B. M. Bakker, et al. 2013. Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. American Journal of Physiology. Gastrointestinal and Liver Physiology 305 (12):G900–G910. doi: 0.1152/ajpgi.00265.2013. doi: 10.1152/ajpgi.00265.2013.
   PubMed Web of Science ®Google Scholar
• Druart, C., A. M. Neyrinck, E. M. Dewulf, F. C. De Backer, S. Possemiers, T. Van de Wiele, F. Moens, L. De Vuyst, P. D. Cani, Y. Larondelle, et al. 2013. Implication of fermentable carbohydrates targeting the gut microbiota on conjugated linoleic acid production in high-fat-fed mice. The British Journal of Nutrition 110 (6):998–1011. doi: 10.1017/s0007114513000123.
   PubMed Web of Science ®Google Scholar
• Du, H., A. Zhao, Q. Wang, X. Yang, and D. Ren. 2020. Supplementation of inulin with various degree of polymerization ameliorates liver injury and gut microbiota dysbiosis in high fat-fed obese mice. Journal of Agricultural and Food Chemistry 68 (3):779–87. doi: 10.1021/acs.jafc.9b06571.
   PubMed Web of Science ®Google Scholar
• Duranti, S., C. Ferrario, D. van Sinderen, M. Ventura, and F. Turroni. 2017. Obesity and microbiota: An example of an intricate relationship. Genes & Nutrition 12 (1):5–18. doi: 10.1186/s12263-017-0566-2.
   PubMedGoogle Scholar
• Falony, G., T. Calmeyn, F. Leroy, and L. D. Vuyst. 2009a. Coculture fermentations of bifidobacterium species and bacteroides thetaiotaomicron reveal a mechanistic insight into the prebiotic effect of inulin-type fructans. Applied and Environmental Microbiology 75 (8):2312–9. doi: 10.1128/aem.02649-08.
   PubMed Web of Science ®Google Scholar
• Falony, G., A. Verschaeren, F. De Bruycker, V. De Preter, K. Verbeke, F. Leroy, and L. De Vuyst. 2009b. In vitro kinetics of prebiotic inulin-type fructan fermentation by butyrate-producing colon bacteria: implementation of online gas chromatography for quantitative analysis of carbon dioxide and hydrogen gas production. Applied and Environmental Microbiology 75 (18):5884–92. doi: 10.1128/aem.00876-09.
   PubMed Web of Science ®Google Scholar
• Ferreiro, A., N. Crook, A. J. Gasparrini, and G. Dantas. 2018. Multiscale evolutionary dynamics of host-associated microbiomes. Cell 172 (6):1216–27. doi: 10.1016/j.cell.2018.02.015.
   PubMed Web of Science ®Google Scholar
• Flint, H. J., K. P. Scott, S. H. Duncan, P. Louis, and E. Forano. 2012. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3 (4):289–306. doi: 10.4161/gmic.19897.
   PubMed Web of Science ®Google Scholar
• Garcia-Perez, I., J. M. Posma, R. Gibson, E. S. Chambers, T. H. Hansen, H. Vestergaard, T. Hansen, M. Beckmann, O. Pedersen, P. Elliott, et al. 2017. Objective assessment of dietary patterns by use of metabolic phenotyping: A randomised, controlled, crossover trial. The Lancet Diabetes & Endocrinology 5 (3):184–95. doi: 10.1016/S2213-8587(16)30419-3.
   PubMed Web of Science ®Google Scholar
• Gérard, P. 2013. Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens (Basel, Switzerland) 3 (1):14–24. doi: 10.3390/pathogens3010014.
   PubMedGoogle Scholar
• Gibson, G. R., R. Hutkins, M. E. Sanders, S. L. Prescott, R. A. Reimer, S. J. Salminen, K. Scott, C. Stanton, K. S. Swanson, P. D. Cani, et al. 2017. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews. Gastroenterology & Hepatology 14 (8):491–502. doi: 10.1038/s41575-020-0344-2.
   PubMed Web of Science ®Google Scholar
• Goodrich, J. K., S. C. Di Rienzi, A. C. Poole, O. Koren, W. A. Walters, J. G. Caporaso, R. Knight, and R. E. Ley. 2014. Conducting a microbiome study. Cell 158 (2):250–62. doi: 10.1016/j.cell.2014.06.037.
   PubMed Web of Science ®Google Scholar
• Gutiérrez, N., and D. Garrido. 2019. Species deletions from microbiome consortia reveal key metabolic interactions between gut microbes. Msystems 4 (4):e00185-19. doi: 10.1128/mSystems.00185-19.
   PubMed Web of Science ®Google Scholar
• Hamaker, B. R., and Y. E. Tuncil. 2014. A perspective on the complexity of dietary fiber structures and their potential effect on the gut microbiota. Journal of Molecular Biology 426 (23):3838–50. doi: 10.1016/j.jmb.2014.07.028.
   PubMed Web of Science ®Google Scholar
• Han, K.-H., Y. Kobayashi, Y. Nakamura, K-i Shimada, T. Aritsuka, K. Ohba, T. Morita, and M. Fukushima. 2014. Comparison of the effects of longer chain inulins with different degrees of polymerization on colonic fermentation in a mixed culture of swine fecal bacteria. Journal of Nutritional Science and Vitaminology 60 (3):206–12. doi: 10.3177/jnsv.60.206.
   PubMed Web of Science ®Google Scholar
• He, Y., C. Wu, J. Li, H. Li, Z. Sun, H. Zhang, P. de Vos, L.-L. Pan, and J. Sun. 2017. Inulin-type fructans modulates pancreatic-gut innate immune responses and gut barrier integrity during experimental acute pancreatitis in a chain length-dependent manner. Frontiers in Immunology 8:1209 doi: 10.3389/fimmu.2017.01209.
   PubMed Web of Science ®Google Scholar
• Healey, G., L. Brough, C. Butts, R. Murphy, K. Whelan, and J. Coad. 2016. Influence of habitual dietary fibre intake on the responsiveness of the gut microbiota to a prebiotic: Protocol for a randomised, double-blind, placebo-controlled, cross-over, single-centre study. Bmj Open 6 (9):e012504. doi: 10.1136/bmjopen-2016-012504.
   PubMed Web of Science ®Google Scholar
• Healey, G., R. Murphy, C. Butts, L. Brough, K. Whelan, and J. Coad. 2018. Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: A randomised, double-blind, placebo-controlled, cross-over, human intervention study. British Journal of Nutrition 119 (2):176–89. doi: 10.1136/bmjopen-2016-012504.
   PubMed Web of Science ®Google Scholar
• Hjorth, M. F., L. Christensen, T. M. Larsen, H. M. Roager, L. Krych, W. Kot, D. S. Nielsen, C. Ritz, and A. Astrup. 2020. Pretreatment prevotella-to-bacteroides ratio and salivary amylase gene copy number as prognostic markers for dietary weight loss. The American Journal of Clinical Nutrition 111 (5):1079–86. doi: 10.1093/ajcn/nqaa007.
   PubMed Web of Science ®Google Scholar
• Holmes, Z. C., J. D. Silverman, H. K. Dressman, Z. Wei, E. P. Dallow, S. C. Armstrong, P. C. Seed, J. F. Rawls, and L. A. David. 2020. Short-chain fatty acid production by gut microbiota from children with obesity differs according to prebiotic choice and bacterial community composition. Mbio 11 (4):e00914-20. doi: 10.1101/2020.04.10.035808.
   Web of Science ®Google Scholar
• Isken, F., S. Klaus, M. Osterhoff, A. F. Pfeiffer, and M. O. Weickert. 2010. Effects of long-term soluble vs. insoluble dietary fiber intake on high-fat diet-induced obesity in C57BL/6J mice. Journal of Nutritional Biochemistry 21 (4):278–84. doi: 10.1016/j.jnutbio.2008.12.012.
   PubMed Web of Science ®Google Scholar
• Jia, W., G. Xie, and W. Jia. 2018. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nature Reviews. Gastroenterology & Hepatology 15 (2):111–28. doi: 10.1038/nrgastro.2017.119.
   PubMed Web of Science ®Google Scholar
• Jiao, N., S. S. Baker, A. Chapa-Rodriguez, W. Liu, C. A. Nugent, M. Tsompana, L. Mastrandrea, M. J. Buck, R. D. Baker, R. J. Genco, et al. 2018. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. Gut 67 (10):1881–91. doi: 10.1136/gutjnl-2017-314307.
   PubMed Web of Science ®Google Scholar
• Joglekar, P., E. D. Sonnenburg, S. K. Higginbottom, K. A. Earle, C. Morland, S. Shapiro-Ward, D. N. Bolam, and J. L. Sonnenburg. 2018. Genetic variation of the SusC/SusD homologs from a polysaccharide utilization locus underlies divergent fructan specificities and functional adaptation in Bacteroides thetaiotaomicron strains. Msphere 3 (3):e00185-18. doi: 10.1128/mSphereDirect.00185-18.
   PubMed Web of Science ®Google Scholar
• Jovel, J.,. J. Patterson, W. Wang, N. Hotte, S. O'Keefe, T. Mitchel, T. Perry, D. Kao, A. L. Mason, K. L. Madsen, et al. 2016. Characterization of the gut microbiome using 16S or shotgun metagenomics. Frontiers in Microbiology 7:459 doi: 10.3389/fmicb.2016.00459.
   PubMed Web of Science ®Google Scholar
• Kaden-Volynets, V.,. C. Günther, J. Zimmermann, J. Beisner, C. Becker, and S. C. Bischoff. 2019. Deletion of the Casp8 gene in mice results in ileocolitis, gut barrier dysfunction, and malassimilation, which can be partially attenuated by inulin or sodium butyrate. The American Journal of Physiology-Gastrointestinal and Liver Physiology 317 (4):G493–G507. doi: 10.1152/ajpgi.00297.2018.
   PubMed Web of Science ®Google Scholar
• Ke, X., A. Walker, S.-B. Haange, I. Lagkouvardos, Y. Liu, P. Schmitt-Kopplin, M. von Bergen, N. Jehmlich, X. He, T. Clavel, et al. 2019. Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice. Molecular Metabolism 22:96–109. doi: 10.1016/j.molmet.2019.01.012.
   PubMed Web of Science ®Google Scholar
• Kelly, G. 2008. Inulin-type prebiotics - A review: Part 1. Alternative Medicine Review : A Journal of Clinical Therapeutic 13 (4):315–29. doi: 10.1136/aim.2009.000596.
   PubMedGoogle Scholar
• Kindt, A., G. Liebisch, T. Clavel, D. Haller, G. Hörmannsperger, H. Yoon, D. Kolmeder, A. Sigruener, S. Krautbauer, C. Seeliger, et al. 2018. The gut microbiota promotes hepatic fatty acid desaturation and elongation in mice. Nature Communications 9 (1):3760 doi: 10.1038/s41467-018-05767-4.
   PubMedGoogle Scholar
• Kliewer, S. A., and D. J. Mangelsdorf. 2015. Bile acids as hormones: The FXR-FGF15/19 pathway. Digestive Diseases (Basel, Switzerland) 33 (3):327–31. doi: 10.1159/000371670.
   PubMed Web of Science ®Google Scholar
• Koh, A., F. De Vadder, P. Kovatcheva-Datchary, and F. B?Ckhed. 2016. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165 (6):1332–45. doi: 10.1016/j.cell.2016.05.041.
   PubMed Web of Science ®Google Scholar
• Kolida, S., D. Meyer, and G. R. Gibson. 2007. A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. European Journal of Clinical Nutrition 61 (10):1189–95. doi: 10.1038/sj.ejcn.1602636.
   PubMed Web of Science ®Google Scholar
• Kolida, S., K. Tuohy, and G. R. Gibson. 2002. Prebiotic effects of inulin and oligofructose. British Journal of Nutrition 87 (S2):S193–S197. doi: 10.1038/sj.ejcn.1602636.
   PubMedGoogle Scholar
• Kolodziejczyk, A. A., D. Zheng, and E. Elinav. 2019. Diet–microbiota interactions and personalized nutrition. Nature Reviews. Microbiology 17 (12):742–12. doi: 10.1038/s41579-019-0256-8.
   PubMed Web of Science ®Google Scholar
• Koropatkin, N. M., E. A. Cameron, and E. C. Martens. 2012. How glycan metabolism shapes the human gut microbiota. Nature Reviews. Microbiology 10 (5):323–35. doi: 10.1038/nrmicro2746.
   PubMed Web of Science ®Google Scholar
• Kumar, M., R. Nagpal, R. Kumar, R. Hemalatha, V. Verma, A. Kumar, C. Chakraborty, B. Singh, F. Marotta, S. Jain, et al. 2012. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Experimental Diabetes Research 2012:902917. doi: 10.1155/2012/902917.
   PubMedGoogle Scholar
• Lambertz, J., S. Weiskirchen, S. Landert, and R. Weiskirchen. 2017. Fructose: A dietary sugar in crosstalk with microbiota contributing to the development and progression of non-alcoholic liver disease. Frontiers in Immunology 8:1159 doi: 10.3389/fimmu.2017.01159.
   PubMed Web of Science ®Google Scholar
• Leylabadlo, H. E., R. Ghotaslou, H. S. Kafil, M. M. Feizabadi, S. Y. Moaddab, S. Farajnia, E. Sheykhsaran, S. Sanaie, D. Shanehbandi, and H. B. Baghi. 2020. Non-alcoholic fatty liver diseases: From role of gut microbiota to microbial-based therapies. European Journal of Clinical Microbiology & Infectious Diseases 39 (4):613–27. doi: 10.1007/s10096-019-03746-1.
   PubMed Web of Science ®Google Scholar
• Li, N., S. Huang, L. Jiang, Z. Dai, T. Li, D. Han, and J. Wang. 2019. Characterization of the early life microbiota development and predominant lactobacillus species at distinct gut segments of low- and normal-birth-weight piglets. Frontiers in Microbiology 10:797. doi: 10.3389/fmicb.2019.00797.
   PubMed Web of Science ®Google Scholar
• Long, S. L., C. G. Gahan, and S. A. Joyce. 2017. Interactions between gut bacteria and bile in health and disease. Molecular Aspects of Medicine 56:54–65. doi: 10.1016/j.mam.2017.06.002.
   PubMed Web of Science ®Google Scholar
• Loughman, A., and H. M. Staudacher. 2020. Treating the individual with diet: Is gut microbiome testing the answer? The Lancet Gastroenterology & Hepatology 5 (5):437. doi: 10.1016/S2468-1253(20)30023-6.
   PubMed Web of Science ®Google Scholar
• Louis, P., H. J. Flint, and C. Michel. 2016. How to manipulate the microbiota: Prebiotics. In Microbiota of the human body: Implications in health and disease, ed. A. Schwiertz, 119–42. doi: 10.1007/978-3-319-31248-4_9.
   Google Scholar
• Macfarlane, G. T., and S. Macfarlane. 2011. Fermentation in the human large intestine its physiologic consequences and the potential contribution of prebiotics. Journal of Clinical Gastroenterology 45:S120–S127. doi: 10.1097/MCG.0b013e31822fecfe.
   PubMed Web of Science ®Google Scholar
• Makki, K., E. C. Deehan, J. Walter, and F. Bäckhed. 2018. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host & Microbe 23 (6):705–15. doi: 10.1016/j.chom.2018.05.003.
   PubMed Web of Science ®Google Scholar
• Mendes-Soares, H., T. Raveh-Sadka, S. Azulay, K. Edens, Y. Ben-Shlomo, Y. Cohen, T. Ofek, D. Bachrach, J. Stevens, D. Colibaseanu, et al. 2019. Assessment of a personalized approach to predicting postprandial glycemic responses to food among individuals without diabetes. JAMA Network Open 2 (2):e188102 doi: 10.1001/jamanetworkopen.2018.8102.
   PubMed Web of Science ®Google Scholar
• Meng, X., G. Zhang, H. Cao, D. Yu, X. Fang, W. M. Vos, and H. Wu. 2020. Gut dysbacteriosis and intestinal disease: Mechanism and treatment. Journal of Applied Microbiology 129 (4):787–805. doi: 10.1111/jam.14661.
   PubMed Web of Science ®Google Scholar
• Molinaro, A., A. Wahlström, and H.-U. Marschall. 2018. Role of bile acids in metabolic control. Trends in Endocrinology & Metabolism 29 (1):31–41. doi: 10.1016/j.tem.2017.11.002.
   PubMed Web of Science ®Google Scholar
• Moreira, G., F. Azevedo, L. Ribeiro, A. Santos, D. Guadagnini, P. Gama, E. Liberti, M. Saad, and C. Carvalho. 2018. Liraglutide modulates gut microbiota and reduces NAFLD in obese mice. The Journal of Nutritional Biochemistry 62:143–54. doi: 10.1016/j.jnutbio.2018.07.009.
   PubMed Web of Science ®Google Scholar
• Mouzaki, M.,. A. Y. Wang, R. Bandsma, E. M. Comelli, B. M. Arendt, L. Zhang, S. Fung, S. E. Fischer, I. G. McGilvray, and J. P. Allard. 2016. Bile acids and dysbiosis in non-alcoholic fatty liver disease. PloS One 11 (5):e0151829. doi: 10.1371/journal.pone.0151829.
   PubMed Web of Science ®Google Scholar
• Murea, M.,. L. Ma, and B. I. Freedman. 2012. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. The Review of Diabetic Studies : RDS 9 (1):6–22. doi: 10.1900/RDS.2012.9.6.
   PubMedGoogle Scholar
• Nicolucci, A. C., M. P. Hume, I. Martinez, S. Mayengbam, J. Walter, and R. A. Reimer. 2017. Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity. Gastroenterology 153 (3):711–22. doi: 10.1053/j.gastro.2017.05.055.
   PubMed Web of Science ®Google Scholar
• Nicolucci, A., and R. Reimer. 2017. Prebiotics as a modulator of gut microbiota in paediatric obesity. Pediatric Obesity 12 (4):265–73. doi: 10.1111/ijpo.12140.
   PubMed Web of Science ®Google Scholar
• Noureddin, M., Zelber, S. ‐Sagi, L. R. Wilkens, J. Porcel, C. J. Boushey, L. L. Marchand, H. R. Rosen, and V. W. Setiawan. 2020. Diet associations with nonalcoholic fatty liver disease in an ethnically diverse population: The Multiethnic Cohort. Hepatology (Baltimore, Md.) 71 (6):1940–52. doi: 10.1002/hep.30967.
   PubMed Web of Science ®Google Scholar
• Nunes-Alves, C. 2016. Microbiome: Microbiota-based nutrition plans . Nature Reviews. Microbiology 14 (1):1 doi: 10.1038/nrmicro.2015.10.
   PubMed Web of Science ®Google Scholar
• Pachikian, B. D., A. Essaghir, J.-B. Demoulin, E. Catry, A. M. Neyrinck, E. M. Dewulf, F. M. Sohet, L. Portois, L.-A. Clerbaux, Y. A. Carpentier, et al. 2013. Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways. Molecular Nutrition & Food Research 57 (2):347–359. doi: 10.1002/mnfr.201200364.
   PubMed Web of Science ®Google Scholar
• Patnode, M. L., Z. W. Beller, N. D. Han, J. Cheng, S. L. Peters, N. Terrapon, B. Henrissat, S. Le Gall, L. Saulnier, D. K. Hayashi, et al. 2019. Interspecies competition impacts targeted manipulation of human gut bacteria by fiber-derived glycans. Cell 179 (1):59–73. e13. doi: 10.1016/j.cell.2019.08.011.
   PubMed Web of Science ®Google Scholar
• Pedersen, H. K., S. K. Forslund, V. Gudmundsdottir, A. Ø. Petersen, F. Hildebrand, T. Hyötyläinen, T. Nielsen, T. Hansen, P. Bork, S. D. Ehrlich, et al. 2018. A computational framework to integrate high-throughput '-omics' datasets for the identification of potential mechanistic links. Nat Protoc 13 (12):2781–2800. doi: 10.1038/s41596-018-0064-z.
   PubMed Web of Science ®Google Scholar
• Perry, R. J., L. Peng, N. A. Barry, G. W. Cline, D. Zhang, R. L. Cardone, K. F. Petersen, R. G. Kibbey, A. L. Goodman, and G. I. Shulman. 2016. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome . Nature 534 (7606):213–217. doi: 10.1038/nature18309.
   PubMed Web of Science ®Google Scholar
• Porras, D., E. Nistal, S. Martínez-Flórez, J. González-Gallego, M. V. García-Mediavilla, and S. Sánchez-Campos. 2018. Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease. Frontiers in Physiology 9:1813. doi: 10.3389/fphys.2018.01813.
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum, S., K. R. Foster, and L. E. Comstock. 2016. The evolution of cooperation within the gut microbiota. Nature 533 (7602):255–259. +. doi: 10.1038/nature17626.
   PubMed Web of Science ®Google Scholar
• Reichardt, N., M. Vollmer, G. Holtrop, F. M. Farquharson, D. Wefers, M. Bunzel, S. H. Duncan, J. E. Drew, L. M. Williams, G. Milligan, et al. 2018. Specific substrate-driven changes in human faecal microbiota composition contrast with functional redundancy in short-chain fatty acid production. The ISME Journal 12 (2):610–622. doi: 10.1038/ismej.2017.196.
   PubMed Web of Science ®Google Scholar
• Rios-Covian, D., S. Arboleya, A. M. Hernandez-Barranco, J. R. Alvarez-Buylla, P. Ruas-Madiedo, M. Gueimonde, and C. G. de los Reyes-Gavilan. 2013. Interactions between bifidobacterium and bacteroides species in cofermentations are affected by carbon sources, including exopolysaccharides produced by bifidobacteria. Applied and Environmental Microbiology 79 (23):7518–7524. doi: 10.1128/aem.02545-13.
   PubMed Web of Science ®Google Scholar
• Riviere, A., M. Selak, A. Geirnaert, P. Van den Abbeele, and L. D. Vuyst. 2018. Complementary mechanisms for degradation of inulin-type fructans and arabinoxylan oligosaccharides among bifidobacterial strains suggest bacterial cooperation. Applied and Environmental Microbiology, ed. J. Björkroth 84 (9):e02893-17. USA: American Society for Microbiology. doi: 10.1128/AEM.02893-17.
   PubMed Web of Science ®Google Scholar
• Rodgers, G. P., and F. S. Collins. 2020. Precision nutrition-the answer to “what to eat to stay healthy”. JAMA 324 (8):735–736. doi: 10.1001/jama.2020.13601.
   PubMed Web of Science ®Google Scholar
• Rodriguez, J., S. Hiel, A. M. Neyrinck, T. Le Roy, S. A. Pötgens, Q. Leyrolle, B. D. Pachikian, M. A. Gianfrancesco, P. D. Cani, N. Paquot, et al. 2020. Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients. Gut 69 (11):1975–1987. doi: 10.1136/gutjnl-2019-319726.
   PubMed Web of Science ®Google Scholar
• Salazar, N., E. M. Dewulf, A. M. Neyrinck, L. B. Bindels, P. D. Cani, J. Mahillon, W. M. de Vos, J.-P. Thissen, M. Gueimonde, C. G. de los Reyes-Gavilán, et al. 2015. Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clinical Nutrition 34 (3):501–507. doi: 10.1016/j.clnu.2014.06.001.
   PubMed Web of Science ®Google Scholar
• Sanz, Y., A. Santacruz, and P. Gauffin. 2010. Gut microbiota in obesity and metabolic disorders. The Proceedings of the Nutrition Society 69 (3):434–441. doi: 10.1017/S0029665110001813.
   PubMed Web of Science ®Google Scholar
• Schnabl, B., and D. A. Brenner. 2014. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146 (6):1513–1524. doi: 10.1053/j.gastro.2014.01.020.
   PubMed Web of Science ®Google Scholar
• Schubert, K., S. W. Olde Damink, M. von Bergen, and F. G. Schaap. 2017. Interactions between bile salts, gut microbiota, and hepatic innate immunity. Immunological Reviews 279 (1):23–35. doi: 10.1111/imr.12579.
   PubMed Web of Science ®Google Scholar
• Schwiertz, A., D. Taras, K. Schäfer, S. Beijer, N. A. Bos, C. Donus, and P. D. Hardt. 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring, Md.) 18 (1):190–195. doi: 10.1038/oby.2009.167.
   PubMed Web of Science ®Google Scholar
• Schwimmer, J. B., J. S. Johnson, J. E. Angeles, C. Behling, P. H. Belt, I. Borecki, C. Bross, J. Durelle, N. P. Goyal, G. Hamilton, et al. 2019. Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease. Gastroenterology 157 (4):1109–1122. doi: 10.1053/j.gastro.2019.06.028.
   PubMed Web of Science ®Google Scholar
• Scott, K. P., J. C. Martin, S. H. Duncan, and H. J. Flint. 2014. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiology Ecology 87 (1):30–40. doi: 10.1111/1574-6941.12186.
   PubMed Web of Science ®Google Scholar
• Seki, E., and B. Schnabl. 2012. Role of innate immunity and the microbiota in liver fibrosis: Crosstalk between the liver and gut. The Journal of Physiology 590 (3):447–458. doi: 10.1113/jphysiol.2011.219691.
   PubMed Web of Science ®Google Scholar
• Serino, M. 2019. SCFAs - the thin microbial metabolic line between good and bad. Nature Reviews. Endocrinology 15 (6):318–319. doi: 10.1038/s41574-019-0205-7.
   PubMed Web of Science ®Google Scholar
• Sharifnia, T., J. Antoun, T. G. C. Verriere, G. Suarez, J. Wattacheril, K. T. Wilson, R. M. Peek, N. N. Abumrad, and C. R. Flynn. 2015. Hepatic TLR4 signaling in obese NAFLD. American Journal of Physiology. Gastrointestinal and Liver Physiology 309 (4):G270–G278. doi: 10.1152/ajpgi.00304.2014.
   PubMed Web of Science ®Google Scholar
• Sharma, P., C. Bhandari, S. Kumar, B. Sharma, P. Bhadwal, and N. Agnihotri. 2018. Dietary fibers: A way to a healthy microbiome. In Diet, microbiome and health. Elsevier, 299–345. doi: 10.1016/B978-0-12-811440-7.00011-9.
   Google Scholar
• Singh, V., B. San Yeoh, A. A. Abokor, R. M. Golonka, Y. Tian, A. D. Patterson, B. Joe, M. Heikenwalder, and M. Vijay-Kumar. 2020. Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota. Gut Microbes 11 (4):1077–1091. doi: 10.1080/19490976.2020.1743492.
   PubMed Web of Science ®Google Scholar
• Singh, V., B. S. Yeoh, B. Chassaing, X. Xiao, P. Saha, R. Aguilera Olvera, J. D. Lapek, L. Zhang, W.-B. Wang, S. Hao, et al. 2018. Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer. Cell 175 (3):679–694. doi: 10.1016/j.cell.2018.09.004.
   PubMed Web of Science ®Google Scholar
• Slavin, J. 2013. Fiber and prebiotics: Mechanisms and health benefits. Nutrients 5 (4):1417–1435. doi: 10.3390/nu5041417.
   PubMed Web of Science ®Google Scholar
• Slavin, J., and J. Feirtag. 2011. Chicory inulin does not increase stool weight or speed up intestinal transit time in healthy male subjects. Food & Function 2 (1):72–77. doi: 10.1039/c0fo00101e.
   PubMed Web of Science ®Google Scholar
• Soderborg, T. K., S. E. Clark, C. E. Mulligan, R. C. Janssen, L. Babcock, D. Ir, B. Young, N. Krebs, D. J. Lemas, L. K. Johnson, et al. 2018. The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD. Nature Communications 9 (1):1–12. doi: 10.1038/s41467-018-06929-0.
   PubMedGoogle Scholar
• Song, X., L. Zhong, N. Lyu, F. Liu, B. Li, Y. Hao, Y. Xue, J. Li, Y. Feng, Y. Ma, et al. 2019. Inulin can alleviate metabolism disorders in ob/ob mice by partially restoring leptin-related pathways mediated by gut microbiota. Genomics, Proteomics & Bioinformatics 17 (1):64–75. doi: CNKI:SUN:GPBI.0.2019-01-007. doi: 10.1016/j.gpb.2019.03.001.
   PubMed Web of Science ®Google Scholar
• Sonnenburg, E. D., H. Zheng, P. Joglekar, S. K. Higginbottom, S. J. Firbank, D. N. Bolam, and J. L. Sonnenburg. 2010. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell 141 (7):1241–1252. doi: 10.1016/j.cell.2010.05.005.
   PubMed Web of Science ®Google Scholar
• Tajadadi-Ebrahimi, M., F. Bahmani, H. Shakeri, H. Hadaegh, M. Hijijafari, F. Abedi, and Z. Asemi. 2014. Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity C-reactive protein among diabetic patients: A double-blind, randomized, controlled clinical trial. Annals of Nutrition & Metabolism 65 (1):34–41. doi: 10.1159/000365153.
   PubMed Web of Science ®Google Scholar
• Tang, Z.-Z., G. Chen, Q. Hong, S. Huang, H. M. Smith, R. D. Shah, M. Scholz, and J. F. Ferguson. 2019. Multi-omic analysis of the microbiome and metabolome in healthy subjects reveals microbiome-dependent relationships between diet and metabolites. Frontiers in Genetics 10:454 doi: 10.3389/fgene.2019.00454.
   PubMed Web of Science ®Google Scholar
• Thaiss, C. A. 2018. Microbiome dynamics in obesity. Science (New York, N.Y.) 362 (6417):903–904. doi: 10.1126/science.aav6870.
   PubMed Web of Science ®Google Scholar
• Tilg, H., N. Zmora, T. E. Adolph, and E. Elinav. 2020. The intestinal microbiota fuelling metabolic inflammation. Nature Reviews. Immunology 20 (1):40–15. doi: 10.1038/s41577-019-0198-4.
   PubMed Web of Science ®Google Scholar
• Tirosh, A., E. S. Calay, G. Tuncman, K. C. Claiborn, K. E. Inouye, K. Eguchi, M. Alcala, M. Rathaus, K. S. Hollander, I. Ron, et al. 2019. The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans. Science Translational Medicine 11 (489):eaav0120. doi: 10.1126/scitranslmed.aav0120.
   PubMed Web of Science ®Google Scholar
• Tremaroli, V., and F. Bäckhed. 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489 (7415):242–249. doi: 10.1038/nature11552.
   PubMed Web of Science ®Google Scholar
• Turnbaugh, P. J., R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (7122):1027–1031. doi: 10.1038/nature05414.
   PubMed Web of Science ®Google Scholar
• Turroni, F., C. Milani, S. Duranti, J. Mahony, D. van Sinderen, and M. Ventura. 2018. Glycan utilization and cross-feeding activities by bifidobacteria. Trends in Microbiology 26 (4):339–350. doi: 10.1016/j.tim.2017.10.001.
   PubMed Web of Science ®Google Scholar
• Vallianou, N. G., T. Stratigou, and S. Tsagarakis. 2018. Microbiome and diabetes: Where are we now? Diabetes Research and Clinical Practice 146:111–118. doi: 10.1016/j.diabres.2018.10.008.
   PubMed Web of Science ®Google Scholar
• van de Wiele, T., N. Boon, S. Possemiers, H. Jacobs, and W. Verstraete. 2007. Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. Journal of Applied Microbiology 102 (2):452–460. doi: 10.1111/j.1365-2672.2006.03084.x.
   PubMed Web of Science ®Google Scholar
• van der Beek, C. M., E. E. Canfora, A. M. Kip, S. H. M. Gorissen, S. W. M. O. Damink, H. M. van Eijk, J. J. Holst, E. E. Blaak, C. H. C. Dejong, and K. Lenaerts. 2018. The prebiotic inulin improves substrate metabolism and promotes short-chain fatty acid production in overweight to obese men. Metabolism 87:25–35. doi: 10.1016/j.metabol.2018.06.009.
   PubMed Web of Science ®Google Scholar
• Van Loo, J. 2004. The specificity of the interaction with intestinal bacterial fermentation by prebiotics determines their physiological efficacy. Nutrition Research Reviews 17 (1):89–98. doi: 10.1079/nrr200377.
   PubMed Web of Science ®Google Scholar
• Vijay-Kumar, M., J. D. Aitken, F. A. Carvalho, T. C. Cullender, S. Mwangi, S. Srinivasan, S. V. Sitaraman, R. Knight, R. E. Ley, and A. T. Gewirtz. 2010. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science (New York, N.Y.) 328 (5975):228–231. doi: 10.1126/science.1179721.
   PubMed Web of Science ®Google Scholar
• Wan, Y.-J Y., and P. K. Jena. 2019. Precision dietary supplementation based on personal gut microbiota. Nature Reviews. Gastroenterology & Hepatology 16 (4):204–206. doi: 10.1038/s41575-019-0108-z.
   PubMed Web of Science ®Google Scholar
• Wang, D., C.-D. Liu, M.-L. Tian, C.-Q. Tan, G. Shu, Q.-Y. Jiang, L. Zhang, and Y.-L. Yin. 2019a. Propionate promotes intestinal lipolysis and metabolic benefits via AMPK/LSD1 pathway in mice. Journal of Endocrinology 243 (3):187–197. doi: 10.1530/JOE-19-0188.
   Web of Science ®Google Scholar
• Wang, X., L. Shi, X. Wang, Y. Feng, and Y. Wang. 2019b. MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis. International Journal of Biological Macromolecules 141:1013–1021. doi: 10.1016/j.ijbiomac.2019.09.007.
   PubMed Web of Science ®Google Scholar
• Weitkunat, K., S. Schumann, K. J. Petzke, M. Blaut, G. Loh, and S. Klaus. 2015. Effects of dietary inulin on bacterial growth, short-chain fatty acid production and hepatic lipid metabolism in gnotobiotic mice. The Journal of Nutritional Biochemistry 26 (9):929–937. doi: 10.1016/j.jnutbio.2015.03.010.
   PubMed Web of Science ®Google Scholar
• Wiele, T., N. Boon, S. Possemiers, H. Jacobs, and W. Verstraete. 2007. Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. Journal of Applied Microbiology 102 (2):452–460. doi: 10.1111/j.1365-2672.2006.03084.x.
   PubMed Web of Science ®Google Scholar
• Xiong, X.,. E. S. Bales, D. Ir, C. E. Robertson, J. L. McManaman, D. N. Frank, and J. Parkinson. 2017. Perilipin-2 modulates dietary fat-induced microbial global gene expression profiles in the mouse intestine. Microbiome 5 (1):1–16. doi: 10.1186/s40168-017-0327-x.
   PubMedGoogle Scholar
• Yang, X., F. He, Y. Zhang, J. Xue, K. Li, X. Zhang, L. Zhu, Z. Wang, H. Wang, and S. Yang. 2019. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice . Alcoholism, Clinical and Experimental Research 43 (3):411–424. doi: 10.1111/acer.13950.
   PubMed Web of Science ®Google Scholar
• Younossi, Z., F. Tacke, M. Arrese, B. Chander Sharma, I. Mostafa, E. Bugianesi, V. Wai-Sun Wong, Y. Yilmaz, J. George, J. Fan, et al. 2019. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 69 (6):2672–2682. doi: 10.1002/hep.30251.
   PubMed Web of Science ®Google Scholar
• Zeevi, D., T. Korem, N. Zmora, D. Israeli, D. Rothschild, A. Weinberger, O. Ben-Yacov, D. Lador, T. Avnit-Sagi, M. Lotan-Pompan, et al. 2015. Personalized nutrition by prediction of glycemic responses. Cell 163 (5):1079–1094. doi: 10.1016/j.cell.2015.11.001.
   PubMed Web of Science ®Google Scholar
• Zhang, Q., H. Yu, X. Xiao, L. Hu, F. Xin, and X. Yu. 2018. Inulin-type fructan improves diabetic phenotype and gut microbiota profiles in rats. PeerJ. 6:e4446. doi: 10.7717/peerj.4446.
   PubMed Web of Science ®Google Scholar
• Zhao, S., C. Jang, J. Liu, K. Uehara, M. Gilbert, L. Izzo, X. Zeng, S. Trefely, S. Fernandez, A. Carrer, et al. 2020. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. Nature 579 (7800):586–591. doi: 10.1038/s41586-020-2101-7.
   PubMed Web of Science ®Google Scholar
• Zhu, Z.,. Y. Huang, X. Luo, Q. Wu, J. He, S. Li, and F. J. Barba. 2019. Modulation of lipid metabolism and colonic microbial diversity of high-fat-diet C57BL/6 mice by inulin with different chain lengths. Food Research International (Ottawa, Ont.) 123:355–363. doi: 10.1016/j.foodres.2019.05.003.
   PubMed Web of Science ®Google Scholar
• Zhu, L., S. Qin, S. Zhai, Y. Gao, and L. Li. 2017. Inulin with different degrees of polymerization modulates composition of intestinal microbiota in mice. FEMS Microbiology Letters 364 (10):fnx075. doi: 10.1093/femsle/fnx075.
   Web of Science ®Google Scholar
• Zmora, N., J. Suez, and E. Elinav. 2019. You are what you eat: Diet, health and the gut microbiota. Nature Reviews. Gastroenterology & Hepatology 16 (1):35–56. doi: 10.1038/s41575-018-0061-2.
   PubMed Web of Science ®Google Scholar